Another Alzheimer’s Drug Showing Promise

The American drug company Eli Lilly said it is seeking the U.S. Food and Drug Administration (FDA) approval for the drug donanemab. If approved, it would be the second Alzheimer’s treatment for delaying the disease. Alzheimer’s affects the brain and causes memory loss and dementia.

Source : https://learningenglish.voanews.com/a/another-alzheimer-s-drug-showing-promise/7184387.html